24 related articles for article (PubMed ID: 38531803)
1. Metabolic pathway-based subtyping reveals distinct microenvironmental states associated with diffuse large B-cell lymphoma outcomes.
Wang X; Liu H; Fei Y; Song Z; Meng X; Yu J; Liu X; Li L; Qiu L; Qian Z; Zhou S; Wang X; Zhang H
Hematol Oncol; 2024 Jul; 42(4):e3279. PubMed ID: 38819002
[TBL] [Abstract][Full Text] [Related]
2. Single-cell and spatial transcriptomics reveal a high glycolysis B cell and tumor-associated macrophages cluster correlated with poor prognosis and exhausted immune microenvironment in diffuse large B-cell lymphoma.
Dai L; Fan G; Xie T; Li L; Tang L; Chen H; Shi Y; Han X
Biomark Res; 2024 Jun; 12(1):58. PubMed ID: 38840205
[TBL] [Abstract][Full Text] [Related]
3. FOXO3 suppresses lymphoma progression through promoting miR-34b/HSPG2 axis.
Tao S; Huang Q; Zhou W; Chen J; Man Y; Chen L; Chen Y
Int J Lab Hematol; 2024 May; ():. PubMed ID: 38775786
[TBL] [Abstract][Full Text] [Related]
4. Analyzing the involvement of diverse cell death-related genes in diffuse large B-cell lymphoma using bioinformatics techniques.
Feng H; Zhang X; Kang J
Heliyon; 2024 May; 10(10):e30831. PubMed ID: 38779021
[TBL] [Abstract][Full Text] [Related]
5. HIV and prior exposure to antiretroviral therapy alter tumour composition and tumour: T-cell associations in diffuse large B-cell lymphoma.
Coelho J; Roush SM; Xu AM; Puranam K; Mponda M; Kasonkanji E; Mulenga M; Tomoka T; Galeotti J; Brownlee A; Ghadially H; Damania B; Painschab M; Merchant A; Gopal S; Fedoriw Y
Br J Haematol; 2024 May; ():. PubMed ID: 38769021
[TBL] [Abstract][Full Text] [Related]
6. 3D microvascular model recapitulates the diffuse large B-cell lymphoma tumor microenvironment in vitro.
Mannino RG; Santiago-Miranda AN; Pradhan P; Qiu Y; Mejias JC; Neelapu SS; Roy K; Lam WA
Lab Chip; 2017 Jan; 17(3):407-414. PubMed ID: 28054086
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and clinicopathological significance of PD-1/PD-L1 expression in the tumor microenvironment and neoplastic cells for lymphoma.
Xie M; Huang X; Ye X; Qian W
Int Immunopharmacol; 2019 Dec; 77():105999. PubMed ID: 31704289
[TBL] [Abstract][Full Text] [Related]
8. Genetic mechanisms underlying tumor microenvironment composition and function in diffuse large B-cell lymphoma.
Cerchietti L
Blood; 2024 Mar; 143(12):1101-1111. PubMed ID: 38211334
[TBL] [Abstract][Full Text] [Related]
9. CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma
Lou X; Zhao K; Xu J; Shuai L; Niu H; Cao Z; Wang J; Zhang Y
Front Immunol; 2022; 13():950213. PubMed ID: 36072582
[TBL] [Abstract][Full Text] [Related]
10. Identifying
Xiang X; Gao LM; Zhang Y; Zhu Q; Zhao S; Liu W; Ye Y; Tang Y; Zhang W
PeerJ; 2023; 11():e16618. PubMed ID: 38099311
[TBL] [Abstract][Full Text] [Related]
11. Blockade of PD-1 and LAG-3 expression on CD8+ T cells promotes the tumoricidal effects of CD8+ T cells.
Ma J; Yan S; Zhao Y; Yan H; Zhang Q; Li X
Front Immunol; 2023; 14():1265255. PubMed ID: 37841254
[TBL] [Abstract][Full Text] [Related]
12. Identification of PLA2G7 as a novel biomarker of diffuse large B cell lymphoma.
Zheng W; Lin Q; Issah MA; Liao Z; Shen J
BMC Cancer; 2021 Aug; 21(1):927. PubMed ID: 34404374
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of IRF8 in tumor cells inhibits the generation of Th17 cells and predicts unfavorable survival of diffuse large B cell lymphoma patients.
Zhong W; Xu X; Zhu Z; Du Q; Du H; Yang L; Ling Y; Xiong H; Li Q
Oncotarget; 2017 Jul; 8(30):49757-49772. PubMed ID: 28537908
[TBL] [Abstract][Full Text] [Related]
14. Analysis and Investigation of Bioinformatics and Epigenetics Reveal the Underlying Mechanisms by which FLOT2 Modulates the Progression of Diffuse Large B-cell Lymphoma.
Zhang Y; Chen Y; Guo Q; Zhang Y; Liu A
Discov Med; 2024 Mar; 36(182):621-631. PubMed ID: 38531803
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
